for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Inspire Medical Systems Inc

INSP.N

Latest Trade

184.99USD

Change

3.01(+1.65%)

Volume

26,309

Today's Range

182.23

 - 

185.36

52 Week Range

40.56

 - 

186.56

As of on the New York Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
181.98
Open
182.23
Volume
26,309
3M AVG Volume
6.73
Today's High
185.36
Today's Low
182.23
52 Week High
186.56
52 Week Low
40.56
Shares Out (MIL)
26.94
Market Cap (MIL)
4,901.66
Forward P/E
-75.80
Dividend (Yield %)
--

Next Event

Inspire Medical Systems Inc at Piper Sandler Healthcare Conference (Virtual)

Latest Developments

More

Inspire Medical Systems Posts Q3 Loss Per Share Of $0.39

Inspire Medical Systems, Inc. Announces Second Quarter 2020 Financial Results And Updates 2020 Outlook

Inspire Medical Systems Q1 Loss Per Share $0.67

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Inspire Medical Systems Inc

Inspire Medical Systems, Inc. is a medical technology company. The Company is focused on the developing and commercialization of minimally invasive solutions for patients with obstructive sleep apnea. The Company has developed a novel, closed-loop solution that continuously monitors a patient's breathing patterns and delivers mild hypoglossal nerve stimulation to maintain an open airway. The system delivers mild stimulation to the hypoglossal nerve, which controls the movement of user's tongue and other key airway muscles. By stimulating these muscles, the airway remains open during sleep. The system is controlled by a small handheld sleep remote.

Industry

Medical Equipment & Supplies

Contact Info

5500 Wayzata Blvd Ste 1600

GOLDEN VALLEY, MN

55416-1237

United States

+1.763.9575037

http://www.inspiremedicalsystems.com

Executive Leadership

Marilyn Carlson Nelson

Independent Chairman of the Board

Timothy P. Herbert

President, Chief Executive Officer, Director

Richard Buchholz

Chief Financial Officer

Philip Ebeling

Chief Operating Officer

Steven Jandrich

Chief Compliance Officer, Vice President of Human Resources

Key Stats

1.69 mean rating - 13 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2018

0.1K

2019

0.1K

2020(E)

0.1K
EPS (USD)

2018

-1.500

2019

-1.400

2020(E)

-2.401
Price To Earnings (TTM)
--
Price To Sales (TTM)
50.91
Price To Book (MRQ)
21.41
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
10.79
LT Debt To Equity (MRQ)
10.79
Return on Investment (TTM)
-27.73
Return on Equity (TTM)
-25.85

Latest News

Latest News

BRIEF-Inspire Medical Systems Announces Cigna Coverage For Inspire Therapy For Treatment Of Obstructive Sleep Apnea

* INSPIRE MEDICAL SYSTEMS - ANNOUNCES CIGNA COVERAGE FOR INSPIRE THERAPY FOR TREATMENT OF OBSTRUCTIVE SLEEP APNEA

BRIEF-Inspire Medical Systems Q1 Loss Per Share $0.67

* INSPIRE MEDICAL SYSTEMS, INC. ANNOUNCES FIRST QUARTER 2020 FINANCIAL RESULTS

BRIEF-Inspire Medical Systems Gets FDA Approval Of Expanded Age Range For Inspire Therapy

* INSPIRE MEDICAL SYSTEMS ANNOUNCES FDA APPROVAL OF EXPANDED AGE RANGE FOR INSPIRE THERAPY

BRIEF-Inspire Medical Systems Prices Offering Of 2 Mln Common Shares At $58/Shr

* INSPIRE MEDICAL SYSTEMS, INC. ANNOUNCES PRICING OF OFFERING OF COMMON STOCK

BRIEF-Inspire Medical Systems Inc Reports Proposed Offering Of Common Stock

* INSPIRE MEDICAL SYSTEMS, INC. ANNOUNCES PROPOSED OFFERING OF COMMON STOCK

BRIEF-Inspire Medical Systems Sees Q1 2020 Revenue Up 31 Percent

* INSPIRE MEDICAL SYSTEMS - PRELIMINARY UNAUDITED Q1 REVENUE EXPECTED TO BE APPROXIMATELY $21.3 MILLION, A 31% INCREASE FROM $16.3 MILLION

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up